County of Santa Clara
County of Santa Clara was paid $175.86M by Medicaid between Jan 2018 and Dec 2024, across 194 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 99% of everything it billed.
SAN JOSE, CA 95128
Next to other Case Manager/Care Coordinator providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 143,553 | $23.95M | |
| 2019 | 171,183 | $23.29M | |
| 2020 | 135,731 | $17.00M | |
| 2021 | 217,748 | $33.68M | |
| 2022 | 173,825 | $22.49M | |
| 2023 | 201,108 | $29.04M | |
| 2024incomplete | 346,504 | $26.42M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 99% | 401,631 | 380,735 | $173.50M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 228,866 | 146,402 | $665K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 54,508 | 36,720 | $211K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 82,833 | 53,764 | $159K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 39,505 | 25,232 | $158K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 32,710 | 22,361 | $136K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 20,907 | 13,269 | $105K |
| 90651 | <1% | 4,782 | 3,206 | $78K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 492 | 279 | $77K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 8,915 | 5,492 | $48K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 6,636 | 6,515 | $47K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,604 | 6,491 | $46K |
182 more codes
| G9012 | Other specified case management service not elsewhere classified | <1% | 600 | $45K |
| 81513 | <1% | 1,388 | $40K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 7,996 | $38K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 2,789 | $30K |
| 99243 | <1% | 3,484 | $27K | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 3,399 | $24K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 6,886 | $24K |
| 87481 | <1% | 1,385 | $21K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,953 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,845 | $19K |
| 99350 | Prolong home eval add 15m | <1% | 1,243 | $19K |
| 99188 | <1% | 9,302 | $17K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 2,441 | $16K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 2,030 | $15K |
| 90715 | <1% | 2,404 | $13K | |
| 86481 | <1% | 797 | $12K | |
| 96112 | <1% | 797 | $12K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,399 | $12K |
| 85027 | <1% | 10,063 | $11K | |
| 92551 | <1% | 7,068 | $11K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,471 | $10K |
| D1206 | Topical application of fluoride varnish | <1% | 3,611 | $10K |
| 90686 | <1% | 37,969 | $8K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,132 | $7K |
| 86780 | <1% | 2,456 | $7K | |
| 96113 | <1% | 613 | $7K | |
| 99349 | <1% | 982 | $7K | |
| 90746 | <1% | 430 | $6K | |
| 86480 | <1% | 765 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,028 | $5K |
| 91321 | <1% | 207 | $5K | |
| 83655 | <1% | 3,098 | $5K | |
| 87653 | <1% | 500 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 8,497 | $5K |
| 99401 | <1% | 874 | $5K | |
| 93325 | <1% | 1,277 | $4K | |
| 90678 | <1% | 233 | $4K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,508 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,516 | $4K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 580 | $3K |
| 99381 | <1% | 382 | $3K | |
| 87631 | <1% | 541 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 78 | $3K |
| 81025 | <1% | 5,097 | $3K | |
| 90680 | <1% | 12,578 | $3K | |
| 93320 | <1% | 939 | $3K | |
| 99242 | <1% | 238 | $3K | |
| 96156 | <1% | 570 | $2K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 12 | $2K |
| 90670 | <1% | 19,021 | $2K | |
| 90698 | <1% | 19,387 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 198 | $2K |
| J3490 | Unclassified drugs | <1% | 6,638 | $2K |
| 87340 | <1% | 1,007 | $2K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 578 | $2K |
| 90697 | <1% | 2,786 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 145 | $2K |
| 80061 | Lipid panel | <1% | 1,093 | $2K |
| 86803 | <1% | 551 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 794 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 434 | $2K |
| 0124A | <1% | 40 | $2K | |
| 91322 | <1% | 58 | $1K | |
| 0081A | <1% | 38 | $1K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 185 | $1K |
| 94760 | <1% | 3,914 | $1K | |
| 87088 | <1% | 942 | $1K | |
| 86762 | <1% | 345 | $1K | |
| 90677 | <1% | 4,034 | $1K | |
| 94010 | <1% | 645 | $1K | |
| 90744 | <1% | 6,132 | $1K | |
| 99173 | <1% | 8,636 | $1K | |
| 90480 | <1% | 43 | $1K | |
| 87905 | <1% | 360 | $1K | |
| 81001 | <1% | 1,388 | $925.58 | |
| 87077 | <1% | 494 | $923.00 | |
| 99343 | <1% | 91 | $914.72 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 532 | $895.36 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,224 | $884.68 |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 319 | $839.57 |
| 99245 | <1% | 314 | $769.36 | |
| 99070 | <1% | 94 | $652.04 | |
| 84439 | <1% | 604 | $577.34 | |
| 87808 | <1% | 269 | $548.74 | |
| 84460 | <1% | 808 | $529.84 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 240 | $480.76 |
| 88142 | <1% | 103 | $434.04 | |
| 82951 | <1% | 85 | $403.54 | |
| 99345 | Prolong home eval add 15m | <1% | 56 | $388.89 |
| 99417 | Prolong home eval add 15m | <1% | 44 | $378.00 |
| 86706 | <1% | 93 | $375.09 | |
| 82728 | <1% | 74 | $361.49 | |
| 99201 | <1% | 12 | $318.27 | |
| 86850 | <1% | 399 | $307.96 | |
| 80076 | <1% | 261 | $304.91 | |
| 86901 | <1% | 399 | $290.05 | |
| 91320 | <1% | 49 | $288.23 | |
| 86704 | <1% | 60 | $281.52 | |
| 86900 | <1% | 399 | $281.26 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 367 | $260.48 |
| 86703 | <1% | 105 | $250.66 | |
| 82947 | <1% | 671 | $224.46 | |
| 83021 | <1% | 38 | $209.54 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 22 | $202.75 |
| 93304 | <1% | 122 | $194.01 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 22 | $190.43 |
| 90633 | <1% | 8,144 | $190.17 | |
| 83550 | <1% | 52 | $131.08 | |
| 97802 | <1% | 22 | $118.14 | |
| 96127 | <1% | 188 | $114.20 | |
| 90688 | <1% | 2,306 | $113.16 | |
| 83540 | <1% | 52 | $108.84 | |
| 91318 | <1% | 173 | $104.12 | |
| 86787 | <1% | 25 | $94.78 | |
| Q0112 | All potassium hydroxide (koh) preparations | <1% | 101 | $85.45 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 26 | $77.16 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 147 | $71.38 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 63 | $60.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $49.58 |
| 90685 | <1% | 1,776 | $45.90 | |
| 81002 | <1% | 733 | $42.10 | |
| 90655 | <1% | 229 | $41.94 | |
| 88141 | <1% | 84 | $41.39 | |
| 90716 | <1% | 1,284 | $32.94 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 109 | $27.44 |
| 99406 | <1% | 22 | $26.24 | |
| 99000 | <1% | 64 | $19.60 | |
| 90619 | <1% | 749 | $16.47 | |
| 90381 | <1% | 58 | $16.47 | |
| 90380 | <1% | 16 | $16.47 | |
| 87102 | <1% | 41 | $10.12 | |
| 3074F | 0% | 61,357 | $0.00 | |
| 3044F | 0% | 3,376 | $0.00 | |
| 90696 | 0% | 300 | $0.00 | |
| 0500F | 0% | 1,240 | $0.00 | |
| 1126F | 0% | 7,373 | $0.00 | |
| 99441 | 0% | 202 | $0.00 | |
| 91319 | 0% | 86 | $0.00 | |
| 3075F | 0% | 1,672 | $0.00 | |
| 90656 | 0% | 3,474 | $0.00 | |
| 3079F | 0% | 3,628 | $0.00 | |
| 1125F | 0% | 422 | $0.00 | |
| Z6402 | 0% | 145 | $0.00 | |
| 3080F | 0% | 166 | $0.00 | |
| Z6406 | 0% | 669 | $0.00 | |
| 90620 | 0% | 469 | $0.00 | |
| 4086F | 0% | 209 | $0.00 | |
| 0503F | 0% | 181 | $0.00 | |
| 3052F | 0% | 12 | $0.00 | |
| 80051 | 0% | 103 | $0.00 | |
| Z6204 | 0% | 138 | $0.00 | |
| 99443 | 0% | 15 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 61 | $0.00 |
| 1111F | 0% | 236 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 105 | $0.00 |
| 96380 | 0% | 63 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 215 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 396 | $0.00 |
| 1159F | 0% | 55,235 | $0.00 | |
| 90461 | 0% | 984 | $0.00 | |
| 3078F | 0% | 58,697 | $0.00 | |
| 1160F | 0% | 16,794 | $0.00 | |
| 0502F | 0% | 7,987 | $0.00 | |
| 90707 | 0% | 1,027 | $0.00 | |
| Z6400 | 0% | 3,678 | $0.00 | |
| 90710 | 0% | 305 | $0.00 | |
| 3077F | 0% | 802 | $0.00 | |
| 82565 | 0% | 105 | $0.00 | |
| Z6300 | 0% | 159 | $0.00 | |
| 90734 | 0% | 605 | $0.00 | |
| Z6304 | 0% | 270 | $0.00 | |
| Z6200 | 0% | 64 | $0.00 | |
| 74018 | 0% | 14 | $0.00 | |
| 0071A | 0% | 47 | $0.00 | |
| 84520 | 0% | 103 | $0.00 | |
| Z6202 | 0% | 59 | $0.00 | |
| 99442 | 0% | 175 | $0.00 | |
| Z6414 | 0% | 75 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 24 | $0.00 |
| 99348 | 0% | 18 | $0.00 | |
| 99254 | 0% | 14 | $0.00 | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| County of Santa Clara | San Jose, CA | $132.37M |
| County of Santa Clara | San Jose, CA | $127.88M |
| County of Santa Clara | San Jose, CA | $106.57M |
| County of Santa Clara | San Jose, CA | $101.97M |
| County of Santa Clara | San Jose, CA | $94.75M |
| County of Santa Clara | Sunnyvale, CA | $70.54M |
| County of Santa Clara | Gilroy, CA | $65.23M |
| County of Santa Clara | Milpitas, CA | $53.78M |
| County of Santa Clara | San Jose, CA | $21.24M |
| County of Santa Clara | San Jose, CA | $20.55M |
| County of Santa Clara | San Jose, CA | $7.82M |
| County of Santa Clara | San Jose, CA | $5.07M |
| County of Santa Clara | San Jose, CA | $2.19M |
| County of Santa Clara | San Jose, CA | $1.28M |
| County of Santa Clara | San Jose, CA | $1.05M |
| County of Santa Clara | San Jose, CA | $900K |
| County of Santa Clara | San Jose, CA | $358K |
| County of Santa Clara | San Jose, CA | $42K |
| County of Santa Clara | Sunnyvale, CA | $38K |
| County of Santa Clara | San Jose, CA | $16K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.